BMS 300 mg 3622 (Reyataz 300 mg)

Generic Name: atazanavir

Pill with imprint BMS 300 mg 3622 is Red / Blue, Capsule-shape and has been identified as Reyataz 300 mg. It is supplied by Bristol-Myers Squibb.

Reyataz is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy. Reyataz 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for BMS 300 mg 3622

Reyataz

Generic Name: atazanavir
Imprint: BMS 300 mg 3622
Strength: 300 mg
Color: Red / Blue
Size: 23.00 mm
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Protease inhibitors
Pregnancy Category: B - No proven risk in humans
CSA Schedule: Not a controlled drug
Labeler / Supplier: Bristol-Myers Squibb
Inactive Ingredients: lactose monohydrate, magnesium stearate, FD&C Blue No. 2, titanium dioxide, ferric oxide red, ferric oxide yellow, isopropyl alcohol, ammonia, propylene glycol, butyl alcohol, alcohol, ferrosoferric oxide, shellac
Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code	Labeler / Repackager
00003-3622
54569-5864	A-S Medication Solutions, LLC (repackager)
54868-5838 (Discontinued)	Physicians Total Care Inc. (repackager)
35356-0114	Lake Erie Medical and Surgical Supply (repackager)